Solvias Group USA Names Jarlath Keating President

Solvias, a global provider of chemistry, manufacturing, and controls (CMC) analytical services, appointed Jarlath Keating as President, Solvias Group USA. In this role, Keating will provide strategic leadership and operational oversight to accelerate Solvias’ growth trajectory in North America and further strengthen its presence in the US market.

Keating has 30 years of experience in the biopharmaceutical and biotechnology sectors, building high-performing teams, fostering customer-focused innovation, and driving commercial success.

He has held senior executive roles at Phosphorex, LLC, Advanced Bioscience Laboratories, and BioReliance, where he delivered strong revenue growth and led international commercial operations across complex, fast-evolving markets.

Solvias has invested in its U.S. capabilities, including the expansion of its Research Triangle Park (RTP), North Carolina facility, and the recent achievement of cGMP readiness. These advancements position Solvias to support biopharmaceutical customers from early-stage development through commercial release with trusted, compliant, and high-quality analytical services.

“We are thrilled to welcome Jarlath Keating to the Solvias leadership team,” said Archie Cullen, CEO of Solvias. “As we scale our U.S. operations to meet the increasing demand for advanced analytical services, Jarlath’s industry expertise and leadership will be instrumental in guiding our next phase of sustainable growth and operational excellence.”